Search
TD-0903
go.drugbank.com/drugs/DB16463InvestigationalTD-0903 was investigated in clinical trials for its potential to treat acute lung injury (ALI) associated with COVID-19, including NCT04350736, NCT05091723 (a pharmacokinetics study in healthy participants
Vabametkib
go.drugbank.com/drugs/DB21629InvestigationalVabametkib has a monoisotopic molecular weight of 566.3 Da.
Fleroxacin
go.drugbank.com/drugs/DB04576ExperimentalFleroxacin is a broad-spectrum antimicrobial fluoroquinolone. It strongly inhibits the DNA-supercoiling activity of DNA gyrase. Fleroxacin is not an inhibitor of CYP1A2.
Etranacogene dezaparvovec
go.drugbank.com/drugs/DB16791ApprovedInvestigational[L45255] Etranacogene dezaparvovec was approved by the EMA in February 2023[L45439,L45444] and by Health Canada in October 2023.[L48801] … [L44156] Etranacogene dezaparvovec was approved by the FDA in November 2022 for the treatment of select patients with hemophilia B, becoming the first gene therapy approved for this indication.
HLX70
go.drugbank.com/drugs/DB16509InvestigationalHLX70, a recombinant humanized anti-S protein monoclonal antibody intended for intravenous infusion, was under investigation in clinical trials NCT05429385 and NCT04561076 to evaluate its safety and pharmacokinetics
Isospaglumic acid
go.drugbank.com/drugs/DB19650InvestigationalIsospaglumic acid has a monoisotopic molecular weight of 304.09 Da.
Bevurogant
go.drugbank.com/drugs/DB21507ExperimentalBevurogant has a monoisotopic molecular weight of 532.2 Da.
Izumerogant
go.drugbank.com/drugs/DB21604ExperimentalIzumerogant has a monoisotopic molecular weight of 495.11 Da.
Glovadalen
go.drugbank.com/drugs/DB21709InvestigationalGlovadalen has a monoisotopic molecular weight of 475.14 Da.